ReviewJPRAS open2026
Reflectance confocal microscopy in the management of lentigo maligna and lentigo maligna melanoma: a systematic review.
Review in JPRAS open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lentigo maligna (LM) and lentigo maligna melanoma (LMM) are difficult to manage because of their subclinical extension and ill-defined margins, especially on chronically sun-damaged facial skin. Reflectance confocal microscopy (RCM), a non-invasive imaging technique with near-histological resolution, has emerged as a valuable adjunct for diagnosis, presurgical margin mapping, and postoperative surveillance. Objective: To systematically review current evidence on the role of RCM in LM and LMM management. Methods: A systematic review was performed in accordance with PRISMA 2020 guidelines. PubMed, Embase, and Scopus were searched up to July 2025. Eligible studies assessed RCM for diagnostic accuracy, presurgical mapping, surgical outcomes, or follow-up. Findings were synthesized qualitatively. Results: Twenty-nine studies were included. Across diverse study designs, RCM demonstrated higher diagnostic accuracy than dermoscopy for LM, with reported sensitivities ranging from 85 % to 100 % and specificities from 71 % to 97 %. In comparative studies and meta-analyses, RCM showed superior specificity compared with dermoscopy and improved discrimination between LM and early invasive LMM. Presurgical RCM margin mapping was associated with higher first-stage clearance rates (up to 63.6 % vs. 34.7 % with standard assessment), fewer surgical stages (mean 1.1-1.2 vs. 1.7-1.9), narrower excision margins, and lower local recurrence rates (approximately 2-5 % vs. up to 13 % in non-RCM series). RCM was also effective for monitoring non-surgical therapies and detecting early recurrences within surgical scars. Major barriers to widespread adoption include cost, limited availability, training requirements, and the absence of standardized protocols. Conclusions: RCM strengthens the management of LM and LMM by improving diagnostic confidence, enabling precise margin mapping, and supporting long-term surveillance. Broader adoption will depend on standardization of mapping techniques, integration into clinical workflows, and validation of artificial intelligence-assisted interpretation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.